Polypeptide
Also known as: long peptide · oligopeptide chain
A polypeptide is a longer, unbranched chain of amino acids joined by peptide bonds; where 'peptide' ends and 'polypeptide' begins is a convention.
Every protein is built from one or more polypeptide chains, and in everyday biochemistry "polypeptide" simply means a long chain of amino acids. Where a peptide ends and a polypeptide begins is not agreed. In its 2020 rulemaking, FDA noted that textbooks and dictionaries show no scientific consensus on certain aspects of the definitions of "peptide" and "protein."
US regulation sidesteps the word "polypeptide" altogether. Under 21 CFR 600.3, a protein is any alpha amino acid polymer with a specific, defined sequence of more than 40 amino acids, and when two or more chains associate as they do in nature, the chains are counted together. FDA also distinguished "polypeptide" from "polypeptide chain": insulin has two chains of 21 and 30 amino acids, which FDA calls amino acid chains, and together they exceed 40, so insulin is a protein under the rule.
Why it matters
The word matters less than the number. If a compound's total sequence is over 40 amino acids, US regulators treat it as a protein and a biological product, not as a peptide. That interpretation took effect on March 23, 2020, the same date approved protein products such as insulin and human growth hormone moved onto the biologics pathway. Peptides of 40 or fewer amino acids were not affected by that change.
For you, "polypeptide" is a size description and nothing more. It does not tell you whether a compound is stable, pure, studied in people, or approved for anything. Those questions have to be answered compound by compound and batch by batch, regardless of the chain's length. When a seller uses the word, ask for the actual sequence and the analytical testing behind the batch.
How to tell where a compound falls
- Find the full amino acid sequence or the residue count from a reliable source.
- If the molecule has more than one chain that associate as they do in nature, add the chains together.
- Compare the total with 40: above 40 is a protein under US regulation; 40 or fewer is a peptide.
- Treat "polypeptide" in a product description as informal wording, not a regulatory status.
Insulin: 21 + 30 = 51 amino acids across two chains. Since 51 is greater than 40, insulin is regulated as a protein, even though neither chain alone reaches 40.
Common mistakes
- Using "polypeptide" as if it named a specific drug class with shared effects.
- Counting only one chain of a multi-chain molecule when comparing it against the 40-amino-acid line.
- Assuming there is a fixed scientific cutoff between peptide and polypeptide.
- Assuming a longer chain means a more potent or more effective compound.
- Assuming the regulatory status of a compound from the word used on a product page instead of from its actual sequence.
Sources
- Reference21 CFR 600.3 -- Definitions. Electronic Code of Federal Regulations (eCFR), 2020.
- GuidelineDefinition of the Term “Biological Product” (Final Rule). Federal Register (U.S. Food and Drug Administration), 2020.
- Guideline“Deemed to be a License” Provision of the BPCI Act. U.S. Food and Drug Administration, 2024.
Page updated . How we grade evidence: methodology.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial